Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | ATRA | FIMM | pan-cancer | AAC | 0.34 | 0.03 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |